Zobrazeno 1 - 10
of 98
pro vyhledávání: '"sodium ferric gluconate complex"'
Autor:
Dajun Sun, Rodney Rouse, Vikram Patel, Yong Wu, Jiwen Zheng, Alokita Karmakar, Anil K. Patri, Priyanka Chitranshi, David Keire, Jia Ma, Wenlei Jiang
Publikováno v:
Nanomaterials, Vol 8, Iss 1, p 25 (2018)
The objective of this study was to evaluate physicochemical equivalence between brand (i.e., Ferrlecit) and generic sodium ferric gluconate (SFG) in sucrose injection by conducting a series of comparative in vitro characterizations using advanced ana
Externí odkaz:
https://doaj.org/article/8dcd983e0a3b4362b3a0e1a71b4e5b4b
Publikováno v:
European Heart Journal. 42
Introduction Patients suffering from heart failure (HF) and iron deficiency (ID) have worse outcomes. Intra-venous (IV) ferric carboxymaltose has been shown to reduce HF readmissions and improve symptoms in patients with HF with reduced ejection frac
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Christopher R. Beekman, Murali K. Matta, Christopher D. Thomas, Adil Mohammad, Sharron Stewart, Lin Xu, Ashok Chockalingam, Katherine Shea, Dajun Sun, Wenlei Jiang, Vikram Patel, Rodney Rouse
Publikováno v:
Nanomaterials, Vol 8, Iss 1, p 10 (2017)
Relative biodistribution of FDA-approved innovator and generic sodium ferric gluconate (SFG) drug products was investigated to identify differences in tissue distribution of iron after intravenous dosing to rats. Three equal cohorts of 42 male Spragu
Externí odkaz:
https://doaj.org/article/f1fa474e3306409daee18855b2720ab3
Publikováno v:
Nanomaterials, Vol 7, Iss 12, p 451 (2017)
Iron deficiency anemia is a common clinical consequence for people who suffer from chronic kidney disease, especially those requiring dialysis. Intravenous (IV) iron therapy is a widely accepted safe and efficacious treatment for iron deficiency anem
Externí odkaz:
https://doaj.org/article/02aff43cfbc642a1859931a629c4b550
Publikováno v:
Journal of cardiovascular pharmacology and therapeutics. 26(4)
Background: The ACC/AHA heart failure (HF) guidelines include a class IIb recommendation for intravenous (IV) iron replacement in patients with iron deficiency and New York Heart Association class II or III to improve functional status and quality of
Publikováno v:
Journal of Electrochemical Science and Engineering, Vol 10, Iss 3 (2020)
Journal of Electrochemical Science and Engineering
Volume 10
Issue 3
Journal of Electrochemical Science and Engineering
Volume 10
Issue 3
Sodium ferric gluconate complex (SFGC) is the third generation of iron supplement of polysaccharide iron (III) complex (PIC). For evaluation of technological level and application value of the prepared SFGC, it would be of great significance to deter
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
W Jiang, Amy Barton Pai, Victoria Cotero, Dan E. Meyer, Manjunath P. Pai, Brian Christopher Bales, N Zheng
Publikováno v:
Clinical and Translational Science. 10:194-200
Emerging data from global markets outside the United States, where many generic iron sucrose formulations are available, have revealed that non-US generic intravenous (i.v.) iron formulations may have iron release profiles that differ from the refere
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.